Liver Cirrhosis Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: L64D5A72146EEN
Market Monitor Global

Abstracts

Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse.

This report contains market size and forecasts of Liver Cirrhosis in Global, including the following market information:

Global Liver Cirrhosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Liver Cirrhosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Alcoholic Cirrhosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liver Cirrhosis include F Hoffman La-Roche, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Merck, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology and Instituto Grifols and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liver Cirrhosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liver Cirrhosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Liver Cirrhosis Market Segment Percentages, by Type, 2021 (%)

• Alcoholic Cirrhosis
• Atrophic Cirrhosis
• Biliary Cirrhosis
• Cardiac Cirrhosis
• Cryptogenic Cirrhosis

Global Liver Cirrhosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Liver Cirrhosis Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics

Global Liver Cirrhosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Liver Cirrhosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liver Cirrhosis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Liver Cirrhosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F Hoffman La-Roche
• GlaxoSmithKline
• Gilead Sciences
• Johnson & Johnson
• Merck
• Bristol-Myers Squibb
• Conatus Pharmaceuticals
• Gwo Xi Stem Cell Applied Technology
• Instituto Grifols
• Intercept Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liver Cirrhosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liver Cirrhosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIVER CIRRHOSIS OVERALL MARKET SIZE

2.1 Global Liver Cirrhosis Market Size: 2021 VS 2028
2.2 Global Liver Cirrhosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Liver Cirrhosis Players in Global Market
3.2 Top Global Liver Cirrhosis Companies Ranked by Revenue
3.3 Global Liver Cirrhosis Revenue by Companies
3.4 Top 3 and Top 5 Liver Cirrhosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liver Cirrhosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Cirrhosis Players in Global Market
  3.6.1 List of Global Tier 1 Liver Cirrhosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Liver Cirrhosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Liver Cirrhosis Market Size Markets, 2021 & 2028
  4.1.2 Alcoholic Cirrhosis
  4.1.3 Atrophic Cirrhosis
  4.1.4 Biliary Cirrhosis
  4.1.5 Cardiac Cirrhosis
  4.1.6 Cryptogenic Cirrhosis
4.2 By Type - Global Liver Cirrhosis Revenue & Forecasts
  4.2.1 By Type - Global Liver Cirrhosis Revenue, 2017-2022
  4.2.2 By Type - Global Liver Cirrhosis Revenue, 2023-2028
  4.2.3 By Type - Global Liver Cirrhosis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liver Cirrhosis Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
5.2 By Application - Global Liver Cirrhosis Revenue & Forecasts
  5.2.1 By Application - Global Liver Cirrhosis Revenue, 2017-2022
  5.2.2 By Application - Global Liver Cirrhosis Revenue, 2023-2028
  5.2.3 By Application - Global Liver Cirrhosis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liver Cirrhosis Market Size, 2021 & 2028
6.2 By Region - Global Liver Cirrhosis Revenue & Forecasts
  6.2.1 By Region - Global Liver Cirrhosis Revenue, 2017-2022
  6.2.2 By Region - Global Liver Cirrhosis Revenue, 2023-2028
  6.2.3 By Region - Global Liver Cirrhosis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Liver Cirrhosis Revenue, 2017-2028
  6.3.2 US Liver Cirrhosis Market Size, 2017-2028
  6.3.3 Canada Liver Cirrhosis Market Size, 2017-2028
  6.3.4 Mexico Liver Cirrhosis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Liver Cirrhosis Revenue, 2017-2028
  6.4.2 Germany Liver Cirrhosis Market Size, 2017-2028
  6.4.3 France Liver Cirrhosis Market Size, 2017-2028
  6.4.4 U.K. Liver Cirrhosis Market Size, 2017-2028
  6.4.5 Italy Liver Cirrhosis Market Size, 2017-2028
  6.4.6 Russia Liver Cirrhosis Market Size, 2017-2028
  6.4.7 Nordic Countries Liver Cirrhosis Market Size, 2017-2028
  6.4.8 Benelux Liver Cirrhosis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Liver Cirrhosis Revenue, 2017-2028
  6.5.2 China Liver Cirrhosis Market Size, 2017-2028
  6.5.3 Japan Liver Cirrhosis Market Size, 2017-2028
  6.5.4 South Korea Liver Cirrhosis Market Size, 2017-2028
  6.5.5 Southeast Asia Liver Cirrhosis Market Size, 2017-2028
  6.5.6 India Liver Cirrhosis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Liver Cirrhosis Revenue, 2017-2028
  6.6.2 Brazil Liver Cirrhosis Market Size, 2017-2028
  6.6.3 Argentina Liver Cirrhosis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Liver Cirrhosis Revenue, 2017-2028
  6.7.2 Turkey Liver Cirrhosis Market Size, 2017-2028
  6.7.3 Israel Liver Cirrhosis Market Size, 2017-2028
  6.7.4 Saudi Arabia Liver Cirrhosis Market Size, 2017-2028
  6.7.5 UAE Liver Cirrhosis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 F Hoffman La-Roche
  7.1.1 F Hoffman La-Roche Corporate Summary
  7.1.2 F Hoffman La-Roche Business Overview
  7.1.3 F Hoffman La-Roche Liver Cirrhosis Major Product Offerings
  7.1.4 F Hoffman La-Roche Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.1.5 F Hoffman La-Roche Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Liver Cirrhosis Major Product Offerings
  7.2.4 GlaxoSmithKline Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Gilead Sciences
  7.3.1 Gilead Sciences Corporate Summary
  7.3.2 Gilead Sciences Business Overview
  7.3.3 Gilead Sciences Liver Cirrhosis Major Product Offerings
  7.3.4 Gilead Sciences Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Liver Cirrhosis Major Product Offerings
  7.4.4 Johnson & Johnson Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Liver Cirrhosis Major Product Offerings
  7.5.4 Merck Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Bristol-Myers Squibb
  7.6.1 Bristol-Myers Squibb Corporate Summary
  7.6.2 Bristol-Myers Squibb Business Overview
  7.6.3 Bristol-Myers Squibb Liver Cirrhosis Major Product Offerings
  7.6.4 Bristol-Myers Squibb Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.6.5 Bristol-Myers Squibb Key News
7.7 Conatus Pharmaceuticals
  7.7.1 Conatus Pharmaceuticals Corporate Summary
  7.7.2 Conatus Pharmaceuticals Business Overview
  7.7.3 Conatus Pharmaceuticals Liver Cirrhosis Major Product Offerings
  7.7.4 Conatus Pharmaceuticals Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.7.5 Conatus Pharmaceuticals Key News
7.8 Gwo Xi Stem Cell Applied Technology
  7.8.1 Gwo Xi Stem Cell Applied Technology Corporate Summary
  7.8.2 Gwo Xi Stem Cell Applied Technology Business Overview
  7.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Major Product Offerings
  7.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.8.5 Gwo Xi Stem Cell Applied Technology Key News
7.9 Instituto Grifols
  7.9.1 Instituto Grifols Corporate Summary
  7.9.2 Instituto Grifols Business Overview
  7.9.3 Instituto Grifols Liver Cirrhosis Major Product Offerings
  7.9.4 Instituto Grifols Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.9.5 Instituto Grifols Key News
7.10 Intercept Pharmaceuticals
  7.10.1 Intercept Pharmaceuticals Corporate Summary
  7.10.2 Intercept Pharmaceuticals Business Overview
  7.10.3 Intercept Pharmaceuticals Liver Cirrhosis Major Product Offerings
  7.10.4 Intercept Pharmaceuticals Liver Cirrhosis Revenue in Global Market (2017-2022)
  7.10.5 Intercept Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Liver Cirrhosis Market Opportunities & Trends in Global Market
Table 2. Liver Cirrhosis Market Drivers in Global Market
Table 3. Liver Cirrhosis Market Restraints in Global Market
Table 4. Key Players of Liver Cirrhosis in Global Market
Table 5. Top Liver Cirrhosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liver Cirrhosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liver Cirrhosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liver Cirrhosis Product Type
Table 9. List of Global Tier 1 Liver Cirrhosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Cirrhosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liver Cirrhosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liver Cirrhosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liver Cirrhosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Liver Cirrhosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liver Cirrhosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liver Cirrhosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Liver Cirrhosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liver Cirrhosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liver Cirrhosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liver Cirrhosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liver Cirrhosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liver Cirrhosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liver Cirrhosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liver Cirrhosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liver Cirrhosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liver Cirrhosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liver Cirrhosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liver Cirrhosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liver Cirrhosis Revenue, (US$, Mn), 2023-2028
Table 30. F Hoffman La-Roche Corporate Summary
Table 31. F Hoffman La-Roche Liver Cirrhosis Product Offerings
Table 32. F Hoffman La-Roche Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Liver Cirrhosis Product Offerings
Table 35. GlaxoSmithKline Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Liver Cirrhosis Product Offerings
Table 38. Gilead Sciences Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Liver Cirrhosis Product Offerings
Table 41. Johnson & Johnson Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Liver Cirrhosis Product Offerings
Table 44. Merck Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Liver Cirrhosis Product Offerings
Table 47. Bristol-Myers Squibb Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 48. Conatus Pharmaceuticals Corporate Summary
Table 49. Conatus Pharmaceuticals Liver Cirrhosis Product Offerings
Table 50. Conatus Pharmaceuticals Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 51. Gwo Xi Stem Cell Applied Technology Corporate Summary
Table 52. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Offerings
Table 53. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 54. Instituto Grifols Corporate Summary
Table 55. Instituto Grifols Liver Cirrhosis Product Offerings
Table 56. Instituto Grifols Liver Cirrhosis Revenue (US$, Mn), (2017-2022)
Table 57. Intercept Pharmaceuticals Corporate Summary
Table 58. Intercept Pharmaceuticals Liver Cirrhosis Product Offerings
Table 59. Intercept Pharmaceuticals Liver Cirrhosis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Liver Cirrhosis Segment by Type in 2021
Figure 2. Liver Cirrhosis Segment by Application in 2021
Figure 3. Global Liver Cirrhosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liver Cirrhosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liver Cirrhosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Cirrhosis Revenue in 2021
Figure 8. By Type - Global Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 12. US Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 16. Germany Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 24. China Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 30. Brazil Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liver Cirrhosis Revenue Market Share, 2017-2028
Figure 33. Turkey Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liver Cirrhosis Revenue, (US$, Mn), 2017-2028
Figure 37. F Hoffman La-Roche Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Conatus Pharmaceuticals Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Instituto Grifols Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Intercept Pharmaceuticals Liver Cirrhosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)